bbs-2 encodes BBS-2, a constituent subunit of the BBSome — the conserved eight-subunit complex that behaves as a vesicle coat adapted for cilia. In mammals BBS2 belongs to the stable core group alongside BBS1, BBS7 and BBS9.
In the nematode the gene is part of the DAF-19 X-box ciliogenic programme, and the protein sits at the ciliary transition zone as well as along the axoneme, where it moves bidirectionally with IFT. Loss leaves cilia assembled but functionally compromised, with transport no longer coordinated between motors. CD BioSciences delivers custom bbs-2 alleles — knockouts, interaction-surface mutants, patient-variant knockins and tag knockins — with full genotype verification.
| Gene symbol | bbs-2 (BBS2, a core BBSome subunit required for complex assembly and basal body docking) |
|---|---|
| Protein product | BBS-2 — a core subunit of the BBSome ciliary coat |
| Mammalian homolog | BBS2; variants cause Bardet-Biedl syndrome 2 |
| Biological role | BBS-2 is one of the subunits that make up the body of the BBSome. Structural and interaction mapping in mammalian systems places BBS2 among the group — with BBS1, BBS7 and BBS9 — that forms the stable core of the complex, rather than the peripheral subunits that come and go. In worms all eight bbs genes are X-box regulated and therefore part of the RFX transcription factor DAF-19 ciliogenic programme, and BBS-2 localises both to the transition zone at the base of the cilium and along the ciliary axoneme, moving bidirectionally by IFT. |
| Loss-of-function phenotype | Loss gives the recognisable BBSome pattern rather than an assembly failure: cilia form and are much longer than those of IFT complex B mutants, but carry structural defects toward the axoneme periphery, and the animals are dye-filling and chemotaxis defective. The mechanistic signature is that the IFT machinery loses coherence — the two motor populations no longer move one coordinated train along the axoneme. |
| Why edit it | The useful thing about working through BBS-2 rather than through an IFT subunit is that it separates assembly from function. Because the axoneme still builds, you can ask what a cilium can and cannot do once its transport system is running uncoordinated — a question that is hard to reach when the organelle never forms. |
| Recommended background | N2 (wild type). Null animals are viable and fertile. Because the defect is quantitative we recommend velocity measurements using a tagged IFT subunit plus chemotaxis indices, rather than dye filling as the primary endpoint. |
| Representative allele | Engineered deletion alleles plus available loss-of-function alleles from the CGC collection; custom CRISPR nulls, interaction-surface mutants that separate core assembly from cargo recognition, patient-variant knockins, and fluorescent or epitope tag knockins available on request. |
bbs-2 at a glance: bbs-2 belongs to the stable BBSome core, so loss disrupts coordination without abolishing assembly. Editing bbs-2 alone is a powerful way to dissect BBS-2 function in vivo, with conserved relevance to human BBS2; variants cause Bardet-Biedl syndrome 2 biology.
gRNA-guided Cas9 cutting with NHEJ repair to introduce frameshift indels, generating premature stop codons and null / strong-loss-of-function bbs-2 alleles.
Homology-directed repair (HDR) inserts GFP / HA / FLAG or other tags at the bbs-2 locus for endogenous expression and subcellular localization studies.
Introduce specific amino-acid substitutions to dissect functional domains and separate catalytic from scaffolding roles of BBS-2.
Build tissue-specific, inducible, or temperature-sensitive configurations and reporter lines for spatiotemporal analysis of BBS-2 function.
If you want to separate the two jobs this subunit does, an interaction-surface mutant is a better first construct than a deletion: it can leave the complex intact while blocking recognition of particular cargo classes. Pair it with a tagged subunit from the core group so you can confirm the complex still assembles in the mutant background.
Define target (knockout / knockin / point mutation), select gRNA(s) and HDR template, confirm against the latest genome build.
Design, validate, and synthesize high-specificity guide RNAs targeting the bbs-2 locus.
Build Cas9 / gRNA delivery construct and, for knockin, the homology-arm repair template.
Perform gonadal microinjection of N2 animals with CRISPR components and co-CRISPR selection markers.
PCR, Sanger / sequencing, and phenotype confirmation to isolate edited animals and verify alleles.
Provide homozygous / balanced bbs-2 strains plus a full genotype and methods report.
Standard knockout projects deliver a frameshift indel allele predicted to produce a premature stop and a loss-of-function phenotype. We confirm the edit by sequencing and, where relevant, by characteristic phenotype assays.
Yes. Using HDR with a designed repair template, we can insert GFP, HA, or FLAG tags at the C- or N-terminus while preserving endogenous promoter and regulation.
Timelines vary with editing type and validation needs, but our optimized pipeline and co-CRISPR selection typically shorten turnaround versus conventional approaches. Contact us with your design for a project-specific estimate.
They overlap substantially but not completely, and treating them as interchangeable is a mistake. In nematodes every locus tested has ciliary abnormalities with a dye-filling defect, and the coordination phenotype is shared. But the severity differs by subunit, and in other systems some subunits are peripheral and dispensable for core assembly in ways the core group is not. If you are choosing one representative, say what you want to represent — core stability, cargo binding, or motor coordination — and pick accordingly rather than defaulting.
CD BioSciences is committed to convenient, efficient, and cost-effective C. elegans model customization. Tell us your target design — knockout, knockin, tagging, or point mutation — and our scientists will respond with a tailored plan and quote.
Contact UsReferences
1. Kim H. M., Colaiácovo M. P. CRISPR-Cas9-guided genome engineering in C. elegans. Current Protocols in Molecular Biology, 2016, 115(1): 31.7.1–31.7.18.
2. Blacque O. E., Reardon M. J., Li C., McCarthy J., Mahjoub M. R., Ansley S. J., Badano J. L., Mah A. K., Beales P. L., Davidson W. S., Johnsen R. C., Audeh M., Plasterk R. H. A., Baillie D. L., Katsanis N., Quarmby L. M., Wicks S. R., Leroux M. R. Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes & Development, 2004, 18(13): 1630–1640.
For research use only.
Copyright © 2026 CD BioSciences. All rights reserved.